NCT02674399View on ClinicalTrials.gov

A Phase 2 Study to Evaluate the Efficacy and Safety of JointStem in Treatment of Osteoarthritis

PHASE2CompletedINTERVENTIONAL

Enrollment

28

Participants

Timeline

Start Date

February 16, 2016

Primary Completion Date

March 12, 2018

Study Completion Date

December 28, 2018

Conditions

Osteoarthritis, Knee

Interventions

DRUG

JointStem

DRUG

Synvisc-One

Trial Locations (2)

90404

Orthopedic Pain Specialists, Santa Monica

94598

Walnut Creek

Sponsors

Collaborators (1)

KCRN Research, LLC

All Listed Sponsors

collaborator

KCRN Research, LLC

INDUSTRY

lead

Nature Cell Co. Ltd.

INDUSTRY

NCT02674399 - A Phase 2 Study to Evaluate the Efficacy and Safety of JointStem in Treatment of Osteoarthritis | Biotech Hunter | Biotech Hunter